中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

EB病毒性肝炎的研究进展

黄姜伟 韩方正

引用本文:
Citation:

EB病毒性肝炎的研究进展

DOI: 10.3969/j.issn.1001-5256.2018.06.043
详细信息
  • 中图分类号: R512.6

Research advances in Epstein-Barr viral hepatitis

  • 摘要: EB病毒性肝炎是由EB病毒感染引起的肝脏炎症反应,大多数为自限性肝炎或轻中度肝损伤,预后良好,少数可发展为慢性肝病、重型肝炎,甚至肝内胆管细胞癌等。该病的临床表现及组织病理学特征缺乏特异性,容易漏诊、误诊,需要引起临床医师更多的关注与重视。介绍了EB病毒的感染机制以及EB病毒性肝炎的相关研究进展。

     

  • [1]YOUNG LS, YAP LF, MURRAY PG.Epstein-Barr virus:more than50 years old and still providing surprises[J].Nat Rev Cancer, 2016, 16 (12) :789-802.
    [2]KOFTERIDIS DP, KOULENTAKI M, VALACHIS A, et al.Epstein Barr virus hepatitis[J].Eur J Intern Med, 2011, 22 (1) :73-76.
    [3]LI M, GAO RP.Investigation and characteristics of Epstein-Barr virus infection among patients with different liver diseases[D].Changchun:Jilin Univ, 2016. (in Chinese) 李敏, 高润平.不同肝病Epstein-Barr virus感染的调查及临床特点分析[D].长春:吉林大学, 2016.
    [4]RAO SC, ASHRAF I, MIR F, et al.Dual infection with hepatitis B and Epstein-Barr virus presenting with severe jaundice, coagulopathy, and hepatitis B virus chronicity outcome[J].Am J Case Rep, 2017, 18:170-172.
    [5]SUN K, XU S, WEI J, et al.Clinicopathological features of 11 Epstein-Barr virus-associated intrahepatic cholangiocarcinoma at a single center in China[J].Medicine, 2016, 95 (40) :e5069.
    [6] WANG XM, TONG M, XU C, et al.Research progress of Epstein-Barr virus-related disease[J].Chin Clin Pract Med, 2016, 7 (3) :98-101. (in Chinese) 王雪萌, 童梅, 徐晨, 等.EB病毒感染及相关疾病的研究进展[J].中国临床实用医学, 2016, 7 (3) :98-101.
    [7]TIAN QH, ZHU SX.Research progress of Epstein-Barr virus-related disease in infants[J].Int J Virol, 2017, 24 (1) :69-72. (in Chinese) 田巧焕, 朱淑霞.儿童EB病毒感染及其相关常见疾病研究进展[J].国际病毒学杂志, 2017, 24 (1) :69-72.
    [8]ABBOTT RJ, PACHNIO A, PEDROZA-PACHECO I, et al.Asymptomatic primary infection with Epstein-Barr virus:Observations on young adult cases[J].J Virol, 2017, 91 (21) :e00382-17.
    [9]KIMURA H, NAGASAKA T, HOSHINO Y, et al.Severe hepatitis caused by Epstein-Barr virus without infection of hepatocytes.[J].Human Pathol, 2001, 32 (7) :757-762.
    [10]GRU AA, HAVERKOS BH, FREUD AG, et al.The EpsteinBarr virus (EBV) in T cell and NK cell lymphomas:Time for a reassessment[J].Curr Hematol Malig Rep, 2015, 10 (4) :456-467.
    [11]MA S, GUO SB, DU TK, et al.Analysis on clinical characteristics and assess immune function of adult with EBV infection[D].Beijing:Peking Union Med Coll, 2016. (in Chinese) 马帅, 郭树彬, 杜铁宽, 等.EBV感染成人临床特点分析及免疫功能评价[D].北京:北京协和医学院, 2016.
    [12]ZHANG H, LI SJ, YUAN YH, et al.The correlation of the liver damage induced by Epstein-Barr virus infection with peripheral blood lymphocyte subsets[J].J Clin Pediatr, 2013, 31 (3) :233-235. (in Chinese) 张慧, 李双杰, 袁远宏, 等.EB病毒感染肝脏损伤与外周血淋巴细胞亚群相关性[J].临床儿科杂志, 2013, 31 (3) :233-235.
    [13]WORTH AJ, HOULDCROFT CJ, BOOTH C.Severe EpsteinBarr virus infection in primary immunodeficiency and the normal host[J].Br J Haematol, 2016, 175 (4) :559-576.
    [14]HOSOI H, SONOKI T, MURATA S, et al.Successful immunosuppressive therapy for severe infectious mononucleosis in a patient with clonal proliferation of EBV-infected CD8-positive cells[J].Intern Med, 2015, 54 (12) :1537-1541.
    [15]CABIBI D.Autoimmune hepatitis following Epstein-Barr virus infection[J].BMJ Case Rep, 2008, 2008:bcr0620080071.
    [16]LI XJ, QU LJ, ZHENG XW, et al.Clinicopathologic features of chronic active Epstein-Barr virus hepatitis[J].World Chin J Dig, 2013, 21 (23) :2325-2330. (in Chinese) 李鑫静, 曲利娟, 郑雄伟, 等.慢性活动性EB病毒性肝炎的临床病理特征[J].世界华人消化杂志, 2013, 21 (23) :2325-2330
    [17]CRUM NF.Epstein Barr virus hepatitis:case series and review[J].South Med J, 2006, 99 (5) :544-547.
    [18]SUH N, LIAPIS H, MISDRAJI J, et al.Epstein-Barr virus hepatitis:diagnostic value of in situ hybridization, polymerase chain reaction, and immunohistochemistry on liver biopsy from immunocompetent patients.[J].Am J Surg Pathol, 2007, 31 (9) :1403-1409.
    [19]YAN W, LI J, REN YY, et al.The levels of liver enzymes and atypical lymphocytes are higher in youth patients with infectious mononucleosis than in preschool children[J].Clin Mol Hepatol, 2013, 19 (4) :382-388.
    [20]TAN ZH, PHUA KB, ONG C, et al.Prolonged hepatitis and jaundice:a rare complication of paediatric Epstein-Barr virus infection[J].Singapore Med J, 2015, 56 (7) :e112-e115.
    [21]LEONARDSSON H, HREINSSON JP, LVE A, et al.Hepatitis due to Epstein-Barr virus and cytomegalovirus:clinical features and outcomes[J].Scand J Gastroenterol, 2017, 52 (8) :893-897.
    [22]VINE LJ, SHEPHERD K, HUNTER JG, et al.Characteristics of Epstein-Barr virus hepatitis among patients with jaundice or acute hepatitis[J].Aliment Pharmacol Ther, 2012, 36 (1) :16-21.
    [23]SALVA I, SILVA I V, CUNHA F.Epstein-Barr virus-associated cholestatic hepatitis[J].BMJ Case Rep, 2013, 2013:bcr2013202213.
    [24]GUPTA E, BHATIA V, CHOUDHARY A, et al.Epstein-Barr virus associated acute hepatitis with cross-reacting antibodies to other herpes viruses in immunocompetent patients:report of two cases.[J].J Med Virol, 2013, 85 (3) :519-523.
    [25]SHAUKAT A, TSAI HT, RUTHERFORD R, et al.Epstein-Barr virus induced hepatitis:An important cause of cholestasis[J].Hepatol Res, 2005, 33 (1) :24-26.
    [26]PETROVA M, KAMBUROV V.Epstein-Barr virus:silent companion or causative agent of chronic liver disease?[J].World J Gastroenterol, 2010, 16 (33) :4130-4134.
    [27]TIAN ZS, WEN XY, WANG CY, et al.Severe liver damage caused by chronic active Epstein-Barr virus infection in children:A report of one ease[J].J Clin Hepatol, 2015, 31 (9) :1488-1489. (in Chinese) 田宗升, 温晓玉, 王重阳, 等.慢性活动性EB病毒感染致严重肝损伤1例报告[J].临床肝胆病杂志, 2015, 31 (9) :1488-1489.
    [28]GAO JX, HUANG Y.Liver cirrhosis caused by chronic active Epstein-Barr virus infection in children:A report of one case[J].Mod J Integr Tradit Chin West Med, 2009, 18 (30) :3758-3759. (in Chinese) 高建兴, 黄莹.慢性活动性EB病毒感染致肝硬化1例[J].现代中西医结合杂志, 2009, 18 (30) :3758-3759.
    [29]QIANG CQ, GENG GH, XU CX, et al.Analysis on the clinical characteristics and prognosis of 104 patients with liver function damage caused by Epstein-Barr virus infection[J/CD].Chin J Exp Clin Infect Dis:Electronic Edition, 2014, 8 (3) :410-413. (in Chinese) 强春倩, 荆国红, 徐学彩, 等.104例EB病毒感染肝功能损害患者的临床特点及预后分析[J/CD].中华实验和临床感染病杂志:电子版, 2014, 8 (3) :410-413.
    [30]SAADAH OI, BOKHARY RY.Anti-mitochondrial antibody positive autoimmune hepatitis triggered by EBV infection in a young girl[J].Arab J Gastroenterol, 2013, 14 (3) :130-132.
    [31]DU HL, SHENG YJ, LI Y, et al.Clinical analysis of 29 cases of EB virus induced hepatitis[J].J Luzhou Med Coll, 2016, 39 (2) :148-150. (in Chinese) 都泓莲, 盛云建, 李烨, 等.EB病毒性肝炎29例临床分析[J].泸州医学院学报, 2016, 39 (2) :148-150.
    [32]PODDIGHE D.Epstein-Barr virus hepatitis:importance of PCR assay/serology and significance ofγ-GTP[J].Pediatr Int, 2017, 59 (8) :947-947.
    [33]DREBBER U, KASPER HU, KRUPACZ J, et al.The role of Epstein-Barr virus in acute and chronic hepatitis[J].J Hepatol, 2006, 44 (5) :879-885.
    [34]JIANG ZF, SHEN KL, SHEN Y.Zhu Futang:Practical paidonosology[M].The 8th Edition.Beijing:People's Medical Publishing House, 2015:916-921. (in Chinese) 江载芳, 申昆玲, 沈颖.诸福棠实用儿科学[M].第8版.北京:人民卫生出版社, 2015:916-921.
    [35]LU HY, WEI XQ, XU XY, et al.A study of the relationship between EBV DNA and EBV antibody levels[J].J Clin Hepatol, 2015, 31 (5) :766-770. (in Chinese) 陆海英, 魏秀琴, 徐小元, 等.EBV抗体与EBV DNA水平的影响因素及其相关性分析[J].临床肝胆病杂志, 2015, 31 (5) :766-770.
    [36]YANG YY, WANG XH, WAN G, et al.Clinical features of liver injury associated with acute Epstein-Barr virus infection inadults:An analysis of 115 cases[J].J Clin Hepatol, 2017, 33 (6) :1141-1144. (in Chinese) 杨玉英, 王欣慧, 万钢, 等.115例成人急性EB病毒感染相关肝损伤临床特征分析[J].临床肝胆病杂志, 2017, 33 (6) :1141-1144.
    [37]RAFAILIDIS PI, MAVROS MN, KAPASKELIS A, et al.Antiviral treatment for severe EBV infections in apparently immunocompetent patients.[J].J Clin Virol, 2010, 49 (3) :151-157.
    [38]ONTANILLA CG, PRAENA SJ, GIRLDEZ G, et al.Severe acute hepatitis and cold agglutinin-related hemolytic anemia secondary to prime infection with Epstein-Barr virus.[J].Rev Esp Enferm Dig, 2017, 109 (5) :388-390.
    [39] RAFAILIDIS PI, MAVROS MN, KAPASKELIS A, et al.Antiviral treatment for severe EBV infections in apparently immunocompetent patients.[J].J Clin Virol, 2010, 49 (3) :151-157.
    [40]MELLINGER JL, ROSSARO L, NAUGLER WE, et al.Epstein-Barr virus (EBV) related acute liver failure:A case series from the US acute liver failure study group[J].Dig Dis Sci, 2014, 59 (7) :1630-1637.
    [41]NAKAZAWA A, NAKANO N, FUKUDA A, et al.Use of serial assessment of disease severity and liver biopsy for indication for liver transplantation in pediatric Epstein-Barr virus-induced fulminant hepatic failure[J].Liver Transpl, 2015, 21 (3) :362-368.
    [42]ADER F, CHATELLIER D, LE BR, et al.Fulminant EpsteinBarr virus (EBV) hepatitis in a young immunocompetent subject[J].Med Mal Infect, 2006, 36 (7) :396-398.
  • 加载中
计量
  • 文章访问数:  2815
  • HTML全文浏览量:  75
  • PDF下载量:  441
  • 被引次数: 0
出版历程
  • 收稿日期:  2017-11-20
  • 出版日期:  2018-06-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回